After Sarepta (SRPT) announced a global licensing and collaboration agreement with Arrowhead (ARWR) that adds four clinical-stage siRNA assets ...
Investor's Business Daily on MSN1h
Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion DealShares of Arrowhead Pharmaceuticals catapulted Tuesday after the company inked a broad licensing deal with Sarepta ...
AtoZ Sports on MSN1h
Chiefs' Isiah Pacheco, Charles Omenihu take the next step in latest injury report for Week 13 vs. RaidersThe Kansas City Chiefs are gearing up for the return of two key playmakers in their first injury report for Week 13.
The Las Vegas Raiders are looking for any way possible to end their seven-game losing streak and get back into the win column. Coach Antonio Pierce’s Raiders a ...
On Friday, the Chiefs return home to Arrowhead on a short week to host the rival Raiders and Butker is still out along with ...
Defense wins championships—or so they say. Let's take a look at every NFL team’s defense and stack rank them from worst to ...
The Chiefs were the first team to appear on a streaming service. Two years ago, Prime Video became the first service with ...
Week 13 of the NFL power rankings sees a shake-up after the "Harbaugh Bowl," with the Ravens flying again as the Chargers ...
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) shares are trading higher Tuesday after the company announced a global ...
The AFC West did not see much impact on the division standings after Week 12. However, many of the teams displayed a great mixture of positives and negatives th ...
For the second consecutive season the NFL will feature one game on Black Friday. Here's what to know about the Black Friday ...
Sarepta Therapeutics and Arrowhead Pharmaceuticals said they have entered a licensing and collaboration agreement worth more than $1 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback